These BiTE can recruit and activate bystander T cells in the tumor microenvironment to attack tumor cells that lack MSLN expression but express NKG2D ligands, thereby demonstrating superior tumor clearance and survival benefits in heterogeneous tumors.138. This evidence concerns the gene KLRK1 and neoplasm.